How do cancer risks predicted from animal bioassays compare with the epidemiologic evidence. The case of ethylene dibromide
Cancer risks for ethylene dibromide (EDB) were estimated by fitting several linear nonthreshold additive models to data from a gavage bioassay. Risks predicted by these models were compared to the observed cancer mortality among a cohort of workers occupationally exposed to the same chemical. Models that accounted for the shortened latency period in the gavaged rats predicted upper bound risks that were within a factor of 3 of the observed cancer deaths. Data from an animal inhalation study of EDB also were compatible with the epidemiologic data. These findings contradict those of Ramsey et al. (1978), who reported that extrapolation from animal data produced highly exaggerated risk estimates for EDB-exposed workers. This paper explores the reasons for these discrepant findings.
- Research Organization:
- California Public Health Foundation, Berkeley (USA)
- OSTI ID:
- 6408567
- Journal Information:
- Risk Anal.; (United States), Vol. 8:2
- Country of Publication:
- United States
- Language:
- English
Similar Records
Semen study of papaya workers exposed to ethylene dibromide
Cytogenetic studies in humans after short-term exposure to ethylene dibromide
Related Subjects
BROMINATED ALIPHATIC HYDROCARBONS
BIOLOGICAL EFFECTS
CARCINOGENS
RISK ASSESSMENT
LABORATORY ANIMALS
BIOASSAY
NEOPLASMS
EPIDEMIOLOGY
COMPARATIVE EVALUATIONS
CORRELATIONS
DATA COVARIANCES
DEATH
DOSE-RESPONSE RELATIONSHIPS
INHALATION
MICE
MORTALITY
OCCUPATIONAL EXPOSURE
PERSONNEL
RATS
STATISTICAL MODELS
ANIMALS
DISEASES
HALOGENATED ALIPHATIC HYDROCARBONS
INTAKE
MAMMALS
MATHEMATICAL MODELS
ORGANIC BROMINE COMPOUNDS
ORGANIC COMPOUNDS
ORGANIC HALOGEN COMPOUNDS
RODENTS
VERTEBRATES
560300* - Chemicals Metabolism & Toxicology